Download PDF
Endoskopie heute 2011; 24(2): 109-116
DOI: 10.1055/s-0031-1271537
Originalarbeit

© Georg Thieme Verlag KG Stuttgart ˙ New York

NBI versus hochauflösende Endoskopie in der Diagnostik von Neoplasien bei Colitis ulcerosa

Narrow-Band Imaging Versus High-Definition Endoscopy for the Diagnosis of Neoplasia in Ulcerative ColitisF. J. C. van den Broek1 , P. Fockens1 , S. van Eeden2 , P. C. F. Stokkers1 , C. Y. Ponsioen1 , J. B. Reitsma3 , E. Dekker1
  • 1Department of Gastroenterology and Hepatology, Academic Medical Centre Amsterdam, The Netherlands
  • 2Department of Pathology, Academic Medical Centre Amsterdam, The Netherlands
  • 3Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Centre Amsterdam, The Netherlands
Further Information

Publication History

Publication Date:
18 July 2011 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Hintergrund und Studienziele: Welche koloskopische Technik für die Diagnostik von Neoplasien bei Patienten mit Colitis ulcerosa am sensitivsten ist, darüber bestehen unterschiedliche Ansichten. Wir verglichen das Narrow-Band-Imaging (NBI) einer neuen Generation mit hochauflösender (high-definition) Endoskopie (HDE) bei der Detektion von Neoplasien und evaluierten NBI bei der Unterscheidung zwischen neoplastischer und nicht-neoplastischer Mukosa. Patienten und Methoden: In einer randomisier­ten Crossvover-Studie wurden Colitis-ulcerosa-Patienten sowohl mit NBI als auch HDE-Koloskopie unter­sucht, wobei zumindest 3 Wochen zwischen den beiden Prozeduren lagen, die von unter­schiedlichen Endoskopikern durchgeführt wurden. Die Läsionen, die bei der Erstunter­suchung detektiert wurden, verblieben in situ, um sie bei der 2. Untersuchung ebenfalls auffinden zu können. Zielkriterien waren 1. die Detektion von Neoplasien, 2. die diagnostische Genauigkeit von NBI bei der Unterscheidung zwischen neoplastischer und nicht-neoplastischer Mukosa anhand der KUDO-Klassifikation und der vaskulären Gefäßintensität (VPI). Ergebnisse: 25 Patienten wurden zuerst zur HDE randomisiert, 26 primär zu NBI. Von 16 neoplas­tischen Läsionen wurden 11 (69 %) durch HDE und 13 (81 %) durch NBI detektiert (p = 0,727). Von 11 Patienten mit Neoplasien wurden 9 (82 %) durch HDE und 8 (73 %) durch NBI detektiert (p = 1,0). Für die KUDO-Klassifikation betrugen Sensitivität 76 %, Spezifität 66 % und die Accuracy 67 %. Für die VPI betrugen die Sensitivität 80 %, die Sepzifität 72 % und die Accuracy 73 %. Schlussfolgerung: NBI verbessert im Vergleich zur HDE bei Patienten mit Colitis ulcerosa die Detek­tion der Neoplasien nicht. NBI lieferte bei der Unterscheidung zwischen neoplastischer und nicht-neoplastischer Mukosa unbefriedigende Resultate. 

Abstract

Background and study aims: Controversy exists about which colonoscopic technique is most sensitive for the diagnosis of neoplasia in patients with ulcerative colitis. We compared new-generation narrow-band imaging (NBI) to high-definition endoscopy (HDE) for the detection of neoplasia and evaluated NBI for the differentiation of neoplastic from non-neoplastic mucosa. Patients and methods: Randomized crossover trial in which patients with ulcerative colitis under­went both NBI and HDE colonoscopy in random order with at least 3 weeks between the two procedures, which were performed by different endoscopists. Lesions detected during the first examination were left in situ in order to enable detection during the second examination as well. Main outcome measures were (1) neoplasia detection, and (2) diagnostic accuracy of NBI for ­differentiating neoplastic from non-neoplastic mucosa by using the Kudo classification and vascular pattern intensity (VPI). Results: Twenty-five patients were randomized to undergo HDE first and 23 to undergo NBI first. Of 16 neoplastic lesions, 11 (69 %) were detected by HDE and 13 (81 %) by NBI (P = 0.727). Of 11 patients with neoplasia, 9 (82 %) were diagnosed by HDE and 8 (73 %) by NBI (P = 1.0). The sensitivity, specificity, and accuracy of the Kudo classification were 76 %, 66 % and 67 %. Corresponding figures for VPI were 80 %, 72 % and 73 %. Conclusion: NBI does not improve the detection of neoplasia in patients with ulcerative colitis compared to HDE. In addition, NBI proves unsatisfactory for differentiating neoplastic from non-neoplastic mucosa.

Schlüsselwörter

NBI - hochauflösende Endoskopie - Colitis ulcerosa - Neoplasien

Key words

NBI - high-definition endoscopy - ulcerative colitis - neoplasia

Literatur

  • 1 Eaden J A, Abrams K R, Mayberry J F. The risk of colorectal cancer in ­ulcerative colitis: a meta-analysis.  Gut. 2001;  48 526-535
    CrossrefPubMedGoogle Scholar
  • 2 Rutter M D, Saunders B P, Wilkinson K H et al. Thirty-year analysis of a ­colonoscopic surveillance program for neoplasia in ulcerative colitis.  Gastroenterology. 2006;  130 1030-1038
    CrossrefPubMedGoogle Scholar
  • 3 Collins P, Mpofu C, Watson A et al. Strategies for detecting colon cancer and / or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev 2006; CD000279
    Google Scholar
  • 4 Rutter M, Bernstein C, Matsumoto T et al. Endoscopic appearance of dysplasia in ulcerative colitis and the role of staining.  Endoscopy. 2004;  36 1109-1114
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Rubin D T, Rothe J A, Hetzel J T et al. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?.  Gastrointest Endosc. 2007;  65 998-1004
    CrossrefPubMedGoogle Scholar
  • 6 Eaden J A, Mayberry J F. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease.  Gut. 2002;  51 V10-V12
    CrossrefPubMedGoogle Scholar
  • 7 Itzkowitz S H, Present D H. Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease.  Inflamm Bowel Dis. 2005;  11 314-321
    CrossrefPubMedGoogle Scholar
  • 8 Dekker E, Fockens P. New imaging techniques at colonoscopy: tissue spectroscopy and narrow band imaging.  Gastrointest Endosc Clin N Am. 2005;  15 703-714
    CrossrefPubMedGoogle Scholar
  • 9 Kiesslich R, Fritsch J, Holtmann M et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis.  Gastroenterology. 2003;  124 880-888
    CrossrefPubMedGoogle Scholar
  • 10 Kiesslich R, Goetz M, Lammersdorf K et al. Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis.  Gastroenterology. 2007;  132 874-882
    CrossrefPubMedGoogle Scholar
  • 11 Rutter M D, Saunders B P, Schofield G et al. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis.  Gut. 2004;  53 256-260
    CrossrefPubMedGoogle Scholar
  • 12 Hurlstone D P, Sanders D S, Lobo A J et al. Indigo carmine-assisted highmagnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation.  Endoscopy. 2005;  37 1186-1192
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Marion J F, Waye J D, Present D H et al. Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial.  Am J Gastroenterol. 2008;  103 2342-2349
    CrossrefPubMedGoogle Scholar
  • 14 Gono K, Obi T, Yamaguchi M et al. Appearance of enhanced tissue features in narrow-band endoscopic imaging.  J Biomed Opt. 2004;  9 568-577
    CrossrefPubMedGoogle Scholar
  • 15 Kuznetsov K, Lambert R, Rey J F. Narrow-band imaging: potential and limitations.  Endoscopy. 2006;  38 76-81
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Gheorghe C. Narrow-band imaging endoscopy for diagnosis of malignant and premalignant gastrointestinal lesions.  J Gastrointest Liver Dis. 2006;  15 77-82
    PubMedGoogle Scholar
  • 17 Dekker E, van den Broek F J, Reitsma J B et al. Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis.  Endoscopy. 2007;  39 216-221
    Article in Thieme ConnectPubMedGoogle Scholar
  • 18 Lichtiger S, Present D H, Kornbluth A et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy.  N Engl J Med. 1994;  330 1841-1845
    CrossrefPubMedGoogle Scholar
  • 19 Schlemper R J, Hirata I, Dixon M F. The macroscopic classification of early neoplasia of the digestive tract.  Endoscopy. 2002;  34 163-168
    Article in Thieme ConnectPubMedGoogle Scholar
  • 20 Kudo S, Rubio C A, Teixeira C R et al. Pit pattern in colorectal neoplasia: endoscopic magnifying view.  Endoscopy. 2001;  33 367-373
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 East J E, Suzuki N, Saunders B P. Comparison of magnified pit pattern interpretation with narrow band imaging versus chromoendoscopy for diminutive colonic polyps: a pilot study.  Gastrointest Endosc. 2007;  66 310-316
    CrossrefPubMedGoogle Scholar
  • 22 Schlemper R J, Riddell R H, Kato Y et al. The Vienna classification of gastrointestinal epithelial neoplasia.  Gut. 2000;  47 251-255
    CrossrefPubMedGoogle Scholar
  • 23 Torlakovic E E, Gomez J D, Driman D K et al. Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA).  Am J Surg Pathol. 2008;  32 21-29
    CrossrefPubMedGoogle Scholar
  • 24 Bossuyt P M, Reitsma J B, Bruns D E et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative.  BMJ. 2003;  326 41-44
    CrossrefPubMedGoogle Scholar
  • 25 Machida H, Sano Y, Hamamoto Y et al. Narrow-band imaging in the diagnosis of colorectal mucosal lesions: a pilot study.  Endoscopy. 2004;  36 1094-1098
    Google Scholar
  • 26 Srivastava A, Redston M, Farraye F A et al. Hyperplastic / serrated polyposis in inflammatory bowel disease: a case series of a previously undescribed entity.  Am J Surg Pathol. 2008;  32 296-303
    CrossrefPubMedGoogle Scholar
  • 27 Rex D K, Helbig C C. High yields of small and flat adenomas with high­definition colonoscopes using either white light or narrow band imaging.  Gastroenterology. 2007;  133 42-47
    CrossrefPubMedGoogle Scholar
  • 28 Aschenbeck J, Adler A, Yenerim T et al. Narrow-band versus white-light HDTV endoscopic imaging for screening colonoscopy: a prospective randomized trial.  Gastroenterology. 2009;  136 410-416
    CrossrefPubMedGoogle Scholar
  • 29 van den Broek F J, Fockens P, van Eeden S et al. Endoscopic tri-modal ­imaging for surveillance in ulcerative colitis: randomized comparison of high resolution endoscopy and autofluorescence imaging for neoplasia detection; and evaluation of narrow band imaging for classification of lesions.  Gut. 2008;  57 1083-1089
    CrossrefPubMedGoogle Scholar
  • 30 Matsumoto T, Kudo T, Jo Y et al. Magnifying colonoscopy with narrow band imaging systemfor the diagnosis of dysplasia in ulcerative colitis: a pilot study.  Gastrointest Endosc. 2007;  66 957-965
    CrossrefPubMedGoogle Scholar
  • 31 van den Broek F J, van Soest E J, Naber A H et al. Combining autofluorescence imaging and narrow-band imaging for the differentiation of adenomas from non-neoplastic colonic polyps among experienced and non-experienced endoscopists.  Am J Gastroenterol. 2009;  104 1498-1507
    CrossrefPubMedGoogle Scholar
  • 32 Pohl J, Lotterer E, Balzer C et al. Computed virtual chromoendoscopy versus standard colonoscopy with targeted indigocarmine chromoscopy: a randomised multicentre trial.  Gut. 2009;  58 73-78
    CrossrefPubMedGoogle Scholar
  • 33 Hoffman A, Kagel C, Goetz M et al. Recognition and characterization of small colonic neoplasia with high-definition colonoscopy using i-Scan is as precise as chromoendoscopy.  Dig Liver Dis. 2010;  42 45-50
    CrossrefPubMedGoogle Scholar
  • 34 Hurlstone D P, Sanders D S, Atkinson R et al. Endoscopic mucosal resection for flat neoplasia in chronic ulcerative colitis: can we change the endoscopic management paradigm?.  Gut. 2007;  56 838-846
    CrossrefPubMedGoogle Scholar
  • 35 Rutter M D, Saunders B P, Wilkinson K H et al. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk.  Gut. 2004;  53 1813-1816
    CrossrefPubMedGoogle Scholar
  • 36 Cairns S R, Scholefield J H, Steele R J et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002).  Gut. 2010;  59 666-689
    CrossrefPubMedGoogle Scholar

Prof. Dr. med. H.-J. Schulz

Sana Klinikum Lichtenberg · Klinik für Innere Medizin I / Gastroenterologie

Fanningerstr. 32

10365 Berlin

Phone: 0 30 / 55 18 22 10

Fax: 0 30 / 55 18 22 50

Email: hj.schulz@sana-kl.de